AI Article Synopsis

  • The study aimed to evaluate the salivary flow rates, perceived oral dryness, and dental caries in patients five years after undergoing hematopoietic cell transplantation (HCT).
  • A total of 39 survivors participated, with results showing a mean unstimulated saliva flow rate of 0.36 mL/min and a stimulated flow rate of 1.02 mL/min, while 73% reported experiencing some level of oral dryness.
  • The findings indicated that there was a slight increase in dental treatments needed post-HCT, with survivors undergoing an average of three treatments over five years following the transplant, although these changes were non-significant when compared to pre-transplant metrics.

Article Abstract

Background: The aim of this study was to describe salivary flow rate, subjective oral dryness and dental caries 5 years post haematopoietic cell transplantation (HCT).

Methods: HCT survivors of a previous longitudinal observational cohort study in the Netherlands (the H-OME study) were invited to participate in this additional follow-up after 5 years (the HOME2 study). During the additional follow-up appointment, stimulated (SWS) and unstimulated whole saliva (UWS) was collected, participants rated subjective oral dryness on a 0 - 10 scale, and caries lesions were assessed. Furthermore, dental records, including treatments and radiographs, were requested for the 5 years preceding and the 5 years following transplantation. Paired t-tests were performed to determine changes in UWS and SWS flow rates and subjective oral dryness from pre-HCT, and to compare the number of caries-related dental treatments (restorations, endodontic treatments or extractions) before and after HCT. Hyposalivation of UWS (< 0.2 mL/min) and SWS (< 0.7 mL/min) at 3 and 12 months, was used to explore the predictive potential of hyposalivation on a high dental treatment need (> 3 treatments) over the 5 years post-HCT.

Results: Five years post-HCT, 39 HCT survivors were included. The mean UWS flow rate was 0.36 mL/min (SD 0.26) and the mean SWS flow rate 1.02 (SD 0.57); survivors were diagnosed with a median of 0 dentine lesions (range 0 - 12) and 73% reported a subjective oral dryness score ≥ 1. Survivors underwent a median of 3 (range 0 - 20) dental treatments during the 5 years following transplantation. The mean difference in UWS 5 years post-HCT compared to pre-HCT was 0.03 (95% CI: -0.07 - 10.12), the mean difference for SWS was -0.18 (95% CI: -0.45 - 0.08) and for subjective oral dryness 1.2 (95% CI: 0.2 - 2.1). In the 5 years post-HCT, non-significantly more treatments were performed compared to the 5 years pre-HCT (mean difference: 0.5, 95%CI: -1.2 - 2.2). Seventy eight percent of patients with hyposalivation of SWS at 12 months had a high dental treatment need, compared with 38% with no hyposalivation.

Conclusions: Five years post-HCT, mean UWS and SWS flow rates were not significantly different from pre-HCT levels but subjective oral dryness scores were elevated.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11389434PMC
http://dx.doi.org/10.1186/s12903-024-04804-7DOI Listing

Publication Analysis

Top Keywords

subjective oral
16
oral dryness
16
salivary flow
8
flow rate
8
rate subjective
8
dryness dental
8
dental caries
8
caries 5 years
8
haematopoietic cell
8
cell transplantation
8

Similar Publications

Background: The Southern Illinois University Longitudinal Cognitive Aging Study (SIU LCAS) is a community-based, longitudinal cohort study initiated in 1984. LCAS was initially designed to improve the sensitivity of neuropsychological testing to diagnose mild cognitive impairment (MCI) and dementia in individuals residing in central and southern Illinois.

Method: Participants are recruited from the community via newspaper advertisement, word-of-mouth, and community presentations.

View Article and Find Full Text PDF

Background: The Women's Alzheimer's Movement Prevention Center (WAMPC) at Cleveland Clinic evaluates women's risk factors for developing Alzheimer's disease and provides personalized recommendations for reducing risk. Previous research has established that up to 40% of Alzheimer's disease (AD) cases might be prevented when modifiable risk factors are addressed. To better understand individual risk profiles, a wealth of information is collected, including self-reported health conditions (both personal and familial), lifestyle factors (e.

View Article and Find Full Text PDF

Background: When it comes to reducing children's fear, anxiety, and discomfort during dental procedures, substantial local anesthetic delivery promotes adequate intervention. In the dental operatory, local anesthetic injections are the most anticipated or feared stimuli. The application of topical anesthetics, cryotherapy, and transcutaneous electrical nerve stimulation (TENS) to the oral mucosa prior to local anesthetic injections can alter pain perception in children.

View Article and Find Full Text PDF

Bidirectional longitudinal associations between subjective oral health and subjective well-being.

Arch Gerontol Geriatr

December 2024

Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.

Objective: This study investigated the bidirectional longitudinal association between subjective oral health (SOH) and subjective well-being (SWB) over time.

Methods: This cohort study was based on a four-wave surveys conducted by the English Longitudinal Study of Aging. SOH was measured by oral impacts on daily performance (OIDP), self-rated oral health (SROH), and SWB was measured by the Center for Epidemiologic Studies-Depression (CES-D) scale, Control, Autonomy, Self-Realization, and Pleasure (CASP-19), and satisfaction with life scale (SWLS).

View Article and Find Full Text PDF

The neuronal ceroid lipofuscinoses (NCLs) are incurable pediatric neurodegenerative diseases characterized by accumulation of lysosomal material and dysregulation of autophagy. Given the promising results of treatment with trehalose, an autophagy inducer, in cell and animal models of NCL, we conducted an open-label, non-placebo-controlled, non-randomized 12-month prospective study in NCL patients receiving oral trehalose (4 g/day). All were treated with a commercially available formulation for 6 months, followed by a 6-month washout.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!